Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTACH: Tenofovir Alafenamide in Cirrhotic Patients With Low-level Hepatitis B Virus DNA Levels
NCT04780204Phase 4Active, not recruiting
- Sponsor
- Asan Medical Center
- Start
- Aug 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by Asan Medical Center. Started Aug 2021; status: active, not recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04780204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780204.